Shares of Horizon Discovery (LON:HZD) have received a consensus recommendation of “Buy” from the seven analysts that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is GBX 236 ($3.29).
HZD has been the topic of several research reports. Peel Hunt initiated coverage on shares of Horizon Discovery in a research note on Tuesday, March 20th. They set a “hold” rating and a GBX 181 ($2.52) price objective on the stock. Numis Securities reissued a “buy” rating and set a GBX 300 ($4.18) price objective on shares of Horizon Discovery in a research note on Tuesday, February 20th. Finally, N+1 Singer dropped their price objective on shares of Horizon Discovery from GBX 250 ($3.49) to GBX 230 ($3.21) and set a “buy” rating on the stock in a research note on Monday, February 19th.
In other news, insider Susan Galbraith bought 70,000 shares of the company’s stock in a transaction dated Monday, February 5th. The shares were purchased at an average price of GBX 179 ($2.50) per share, for a total transaction of £125,300 ($174,755.93). Also, insider Jonathan Milner bought 370,000 shares of the company’s stock in a transaction dated Thursday, April 5th. The stock was purchased at an average price of GBX 132 ($1.84) per share, for a total transaction of £488,400 ($681,171.55). In the last quarter, insiders bought 834,492 shares of company stock worth $125,549,180.
Horizon Discovery Company Profile
Horizon Discovery Group plc, a life science company, engages in precision gene editing to design, build, and apply cells to advance human health worldwide. Its core capabilities are built around its proprietary transnational genomics platform, a suite of gene editing tools, such as rAAV, ZFN, and CRISPR to alter gene sequence in human or mammalian cell-lines.
Receive News & Ratings for Horizon Discovery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Discovery and related companies with MarketBeat.com's FREE daily email newsletter.